Ghrelin Receptor Biology

Growth hormone secretagogues (GHSs) exert their effects primarily through the growth hormone secretagogue receptor type 1a (GHSR-1a), a G-protein-coupled receptor expressed predominantly in the anterior pituitary and hypothalamus. The endogenous ligand for GHSR-1a is ghrelin, an acylated 28-amino-acid peptide produced in the stomach.

Synthetic GHSs — including the GHRP class — mimic and amplify the ghrelin signal. Upon GHSR-1a activation, the receptor couples to Gαq/11 proteins, triggering phospholipase C, IP3 generation, and intracellular calcium release. This cascade stimulates somatotroph cells to secrete GH in a pulsatile pattern.

Somatotropin Release Mechanism

Native GH release involves a tightly regulated interplay between two hypothalamic factors: growth hormone-releasing hormone (GHRH), which stimulates release, and somatostatin, which inhibits it. GHRPs act synergistically with GHRH by amplifying GH pulses via a distinct signaling pathway — a key reason that GHRP/GHRH analog combinations are frequently studied in preclinical models.

Mod GRF 1-29 (CJC-1295 no DAC) is a stabilized synthetic analog of endogenous GHRH(1-29). Four amino acid substitutions enhance resistance to dipeptidyl aminopeptidase IV (DPP-IV) degradation, extending the active half-life from minutes to approximately 30 minutes in rodent studies.

The Melanocortin Receptor Family

The melanocortin system comprises five GPCRs (MC1R–MC5R), all activated by peptides derived from proopiomelanocortin (POMC). POMC is a large precursor protein cleaved in a tissue-specific manner to produce α-MSH, β-MSH, γ-MSH, and ACTH — each with distinct receptor selectivity profiles.

MC1R is expressed primarily in melanocytes and governs eumelanin (brown/black) vs. phaeomelanin (red/yellow) production. MC4R is expressed centrally in the hypothalamus and is a critical node in the regulation of energy balance, food intake, and thermogenesis. MC3R and MC5R have broader tissue distribution and are studied in immune modulation and exocrine function, respectively.

Melanotan II Pharmacology

Melanotan II (MT-II) is a cyclic heptapeptide analogue of α-MSH incorporating an Nle⁴ and D-Phe⁷ substitution. These modifications confer resistance to proteolytic degradation and a potency approximately 1000-fold greater than native α-MSH at MC1R. MT-II’s broad receptor activation profile (MC1R/3R/4R/5R) makes it a valuable tool compound for disentangling the contributions of individual receptor subtypes in melanogenesis and appetite research.

Semax & BDNF Upregulation

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic derivative of the ACTH(4-7) fragment — a region of ACTH without corticotropic activity. Research interest in Semax centers on its ability to modulate brain-derived neurotrophic factor (BDNF) expression and downstream TrkB signaling in rodent models.

BDNF is a critical regulator of neuronal survival, synaptic plasticity, and long-term potentiation (LTP) — the cellular substrate of learning and memory. Semax has shown significant upregulation of BDNF mRNA in the hippocampus and frontal cortex in animal models, with parallel improvements observed in maze-based learning tasks. It also shows documented neuroprotective effects in ischemia models via reduction of oxidative stress markers.

Selank & GABAergic Modulation

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide Tuftsin with a Pro-Gly-Pro extension conferring proteolytic stability. Its anxiolytic profile in rodent models is attributed to positive modulation of GABA-A receptor function, producing benzodiazepine-like behavioral outcomes without sedation or muscle relaxation in preclinical settings.

Unlike classical anxiolytics, Selank also upregulates enkephalins — endogenous opioid neuropeptides involved in mood regulation — adding a secondary mechanism distinct from pure GABAergic activity. This dual action makes it an interesting mechanistic probe in anxiety models.

TB-500 & the Thymosin β4 Fragment

Thymosin β4 (Tβ4) is a 43-amino-acid endogenous peptide and the principal actin-sequestering protein in eukaryotic cells. It sequesters G-actin monomers, regulating the pool available for F-actin polymerization. This dynamic control of actin availability is fundamental to cell migration, wound closure, and vascular remodeling.

TB-500 represents the active fragment of Tβ4 (residues 17-23: LKKTETQ), shown in multiple studies to retain the parent compound’s ability to promote cell migration and angiogenesis. Its small size confers superior tissue penetration compared to the full Tβ4 molecule in in-vivo rodent wound healing models.

GHK-Cu: Copper Tripeptide Biology

Glycyl-L-histidyl-L-lysine (GHK) is a naturally occurring tripeptide isolated from human plasma. Its affinity for copper(II) ions is exceptionally high (Kd ~10⁻¹⁴ M), forming a stable complex. The GHK-Cu complex has been documented to stimulate collagen synthesis in fibroblast models, upregulate matrix metalloproteinases for tissue remodeling, and suppress pro-inflammatory cytokines including TNF-α and IL-6 in in-vitro systems.